Switzerland· 68534001
Sondelbay 20 mcg/80 mcl, Injektionslösung im Fertigpen
A teriparatide product containing teriparatidum adnr, registered in Switzerland by Accord Healthcare AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Teriparatide is registered in 18 of 19 countries.
Countries holding a registration under ATC H05AA02 (teriparatide), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Teriparatide · ATC H05AA02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of teriparatide costs, country by country.
Normalised to the WHO defined daily dose (20 mcg), so markets compare like for like.
- Switzerland: $26.86 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Teriparatide · price per daily dose (20 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$26.86
The record
At a glance
Swissmedic (Switzerland)- Active substance
- teriparatidum ADNr
- Manufacturer
- Accord Healthcare AG
- Country
- Switzerland (CH)
- ATC code
- H05AA02
- ATC class
- Teriparatide
- Defined daily dose
- 20 mcg, P
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680685340016Fertpen 2.4 mlCHF 278.4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for teriparatide.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Teriparatide · interactions on record
6 records
- 4 moderate
- 2 minor
Most severe, free to view
- DigitoxinC01AA04moderate
- DigoxinC01AA05moderate
- CalcipotriolD05AX02moderate
- CalcitriolD05AX03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Teriparatide in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainDURATIL 20 MICROGRAMOS/80 MICROLITROS SOLUCION INYECTABLE EN PLUMA PRECARGADA EFGGp Pharm S.A.
- SwedenForsteo 20 mikrogram/80 mikroliter Injektionsvätska, lösning i förfylld injektionspennaEli Lilly Nederland B.V.
- BelgiumForsteo 20 µg/80 µlEli Lilly Nederland
- ItalyFORSTEOELI LILLY NEDERLAND BV
- IrelandForsteo 20 micrograms/80 microliters solution for injection in pre-filled penEli Lilly Nederland B.V.
- NorwayForsteoOrifarm AS
- CzechiaFORSTEOEli Lilly Nederland B.V., Utrecht
- United StatesBonsityAlvogen Inc.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Teriparatid +pharma, Teriparatid Cipla
- Bulgaria · Osteoteri
- Cyprus · Bonamens
- Germany · Osteoteri, Teriparatid Ambio Pharma
- Denmark · Tetridar
- Spain · Duratil, Osdy
- France · Teriparatide Ambio Pharma, Teriparatide Biogaran
- United Kingdom (Northern Ireland) · Movymia, Teriparatide Ambio Pharma
- Greece · Bonamens, Osteorel
- Croatia · Teriparatid Pliva
- Hungary · Osteoteri, Teriparatid Teva
- Ireland · Teriparatide Cipla, Tetridar
- Iceland · Forsteo, Kauliv
- Italy · Oseffyl, Patride
- Liechtenstein · Forsteo, Kauliv
- Netherlands · Teriparatide Ambio Pharma, Teriparatide Aristo
- Norway · Forsteo, Kauliv
- Poland · Osteoteri
- Portugal · Teriparatida Ratiopharm
- Sweden · Teriparatide Ambio Pharma, Teriparatide Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95cd2349-6ce9-4b93-8a09-504f32f61e7c GET /v1/drugs/95cd2349-6ce9-4b93-8a09-504f32f61e7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "teriparatidum adnr 250 mcg",
"valid_from": "2022-11-01",
"limitations": "[{\"description\":\"Zur second line-Behandlung von postmenopausalen Frauen und Männern mit neuen radiologisch dokumentierten osteoporosebedingten Wirbelkörperfrakturen, die nach einer mindestens 6-monatigen Therapie mit Calcitonin, SERM (selektiver Oestrogen-Rezeptor-Modulator), Denosumab oder einem Bisphosphonat auftraten.<br>\\nZur Behandlung von Männern und Frauen mit etablierter Glukokortikoid-induzierter Osteoporose (GIOP) bei ungenügender Wirksamkeit oder schlechter Verträglichkeit einer Therapie mit einem Bisphosphonat.<br>\\nMaximale Therapiedauer 24 Monate.<br>\\nDie Indikationsstellung darf nur durch Fachärzte (Endokrinologen, Rheumatologen) erfolgen. \\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-11-01\"}]",
"galenic_form": "Inj Lös 20 mcg/80 mcl",
"therapeutic_area": null,
"sl_inclusion_date": "2022-11-01",
"self_retention_pct": 10
}See everything about teriparatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.